Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/17677
Title: Results of the first interim analysis of the RAPPER II trial in patients with spinal cord injury: ambulation and functional exercise programs in the REX powered walking aid.
Authors: Birch, Nick;Graham, Jon;Priestley, Tom;Heywood, Chris;Sakel, Mohamed;Gall, Angela;Nunn, Andrew;Signal, Nada
Affiliation: The Chris Moody Rehabilitation Centre, Moulton College, Moulton, Northampton, UK
PhysioFunction Ltd, The Chris Moody Rehabilitation Centre, Moulton College, Northampton, UK
Rex Bionics PLC, London, UK
NeuroRehabilitation, East Kent Hospitals University NHS Foundation Trust, Ethelbert Road, Canterbury, UK
London Spinal Cord Injury Centre, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, UK
Victorian Spinal Cord Service, Austin Health, Heidelberg, Victoria, Australia
AUT University, Auckland, New Zealand
Issue Date: 19-Jun-2017
EDate: 2017-06-19
Citation: Journal of neuroengineering and rehabilitation 2017; 14(1): 60
Abstract: The RAPPER II study investigates the feasibility, safety and acceptability of using the REX self-stabilising robotic exoskeleton in people with spinal cord injury (SCI) who are obligatory wheelchair users. Feasibility is assessed by the completion of transfer into the REX device, competency in achieving autonomous control and completion of upper body exercise in an upright position in the REX device. Safety is measured by the occurrence of serious adverse events. Device acceptability is assessed with a user questionnaire. RAPPER II is a prospective, multi-centre, open label, non-randomised, non-comparative cohort study in people with SCI recruited from neurological rehabilitation centres in the United Kingdom, Australia and New Zealand. This is the planned interim report of the first 20 participants. Each completed a transfer into the REX, were trained to achieve machine control and completed Timed Up and Go (TUG) tests as well as upper body exercises in standing in a single first time session. The time to achieve each task as well as the amount of assistance required was recorded. After finishing the trial tasks a User Experience questionnaire, exploring device acceptability, was completed. All participants could transfer into the REX. The mean transfer time was 439 s. Nineteen completed the exercise regime. Eighteen could achieve autonomous control of the REX, 17 of whom needed either no assistance or the help of just one therapist. Eighteen participants completed at least one TUG test in a mean time of 313 s, 15 with the assistance of just one therapist. The questionnaire demonstrated high levels of acceptability amongst users. There were no Serious Adverse Events. This first interim analysis of RAPPER II shows that it is feasible and safe for people with SCI to use the REX powered assisted walking device to ambulate and exercise in. Participants with tetraplegia and paraplegia could walk and perform a functional exercise program when standing needing only modest levels of assistance in most cases. User acceptability was high. ClinicalTrials.gov , NCT02417532 . Registered 11 April 2015.
URI: http://ahro.austin.org.au/austinjspui/handle/1/17677
DOI: 10.1186/s12984-017-0274-6
ORCID: 0000-0002-8601-0888
PubMed URL: 28629390
Type: Journal Article
Subjects: Assistive technology
Paraplegia
Physiotherapy, Rehabilitation, Robotics
Powered walking aid
Spinal cord injury
Tetraplegia
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.